Nemaura Medical Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year Ending	TTM	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	2017 - 2013
Net Income	-6.3	-25.1	-13.89	-6.26	-4.16	-4.45	Upgrade
Depreciation & Amortization	0.49	0.44	0.23	0.1	0.05	0.03	Upgrade
Share-Based Compensation	0	0	0.22	0.11	0.57	0	Upgrade
Other Operating Activities	-3.75	16.21	6.93	0.05	0.09	0.86	Upgrade
Operating Cash Flow	-9.57	-8.45	-6.5	-6	-3.45	-3.56	Upgrade
Capital Expenditures	-0.18	-0.54	-0.96	-0.84	-0.21	-0.08	Upgrade
Change in Investments	-	-	-	-	-	-4.48	Upgrade
Other Investing Activities	-	-	-	-	-	8.97	Upgrade
Investing Cash Flow	-0.18	-0.54	-0.96	-0.84	-0.21	4.4	Upgrade
Common Stock Issued	8.39	8.39	3.12	15.75	0.15	2.47	Upgrade
Other Financing Activities	-5.72	-6.31	-9.49	22.24	-0.06	-0.42	Upgrade
Financing Cash Flow	2.68	2.08	-6.37	37.99	0.1	2.05	Upgrade
Net Cash Flow	-7.2	-7.64	-14.12	31.76	-3.63	2.92	Upgrade
Free Cash Flow	-9.74	-8.99	-7.46	-6.83	-3.66	-3.64	Upgrade
Free Cash Flow Margin	-	-11669.95%	-1480.54%	-	-	-	Upgrade
Free Cash Flow Per Share	-0.34	-0.36	-0.32	-0.31	-0.18	-0.20	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.